Natixis Advisors LLC Acquires 18,094 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Natixis Advisors LLC boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 10.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 193,989 shares of the company's stock after purchasing an additional 18,094 shares during the quarter. Natixis Advisors LLC owned about 0.21% of Acadia Healthcare worth $12,301,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after buying an additional 248 shares in the last quarter. GAMMA Investing LLC raised its stake in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Acadia Healthcare in the second quarter worth about $59,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare during the 3rd quarter valued at approximately $86,000.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research report on Monday. Deutsche Bank Aktiengesellschaft boosted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Barclays cut their price target on Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating on the stock in a research note on Monday, September 30th. StockNews.com raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, November 14th. Finally, Cantor Fitzgerald reiterated a "neutral" rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $83.33.

Acadia Healthcare Trading Down 1.3 %

Shares of NASDAQ:ACHC traded down $0.51 during mid-day trading on Thursday, hitting $38.59. The company had a trading volume of 1,467,286 shares, compared to its average volume of 1,012,567. The company has a market capitalization of $3.58 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.64 and a beta of 1.33. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77. The firm has a fifty day moving average price of $54.95 and a 200 day moving average price of $64.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period in the previous year, the company posted $0.91 EPS. The firm's revenue was up 8.7% compared to the same quarter last year. As a group, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.